Clinics
Age and sex: 58 years old male patient Previous History : preleukemia; no previous malignant disease; no inborn condition of note. Organomegaly : no hepatomegaly; no splenomegaly; no enlarged lymph nodes; no central nervous system involvement.
Blood
WBC: 1.9 x 10 9 /l; Hb: 9.1 g/dl; platelets: 282x 10 9 /l. Bone marrow: 1.4% blasts Other molecular cytogenetic technics: FISH using the BAC probe RP11-375H16 (2q23.1). Other molecular cytogenetics results: 59% normal metaphases and 41% of metaphases with 3 chromosomes 2.
Cytopathology classification
G-banding karyotype revealed isolated trisomy 2 of case 1.
Comments
Trisomy 2 as single chromosomal abnormality appears to be associated with MDS on the contrary to AML where it is frequently encountered in association to other unbalanced chromosomal abnormalities [ref.1] . This observation therefore suggests that trisomy 2 could be an early genetic abnormality in MDS. Indeed, from the 9 MDS/AML described cases with isolated trisomy 2 (including our 2 cases), 7 cases revealed isolated trisomy 2 at MDS presentation. MDS in transformation was diagnosed among the 4 oldest patients, though age does not carry prognostic Isolated trisomy 2 is non-random and may be found in myelodysplastic syndrome Roche-Lestienne C et al. and in acute myeloblastic leukaemia. Case 1 Atlas Genet Cytogenet Oncol Haematol. 2007; 11(1) 62 significance according to the IPSS [ref.2] . 5 of the 9 published cases evolved to acute leukaemia.
